Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00315-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2011English

HIV-1 Integrase Inhibitors to Treat AIDS

2015English

Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer Inhibitors

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2019English

Figure 1: FDA Approved Integrase Strand Transfer Inhibitors INSTIs: Raltegravir, Elvitegravir and Dolutegravir.

English

Peptide HIV-1 Integrase Inhibitors From HIV-1 Gene Products

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based ART Regimen

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2020English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

HIV1 Integrase Strand Transfer Inhibitors With Reduced Susceptibility to Drug Resistant Mutant Integrases

English

CoMFA and CoMSIA Studies on Inhibitors of HIV-1 Integrase - Bicyclic Pyrimidinones

E-Journal of Chemistry
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy